Skip to main content
Figure 5 | BMC Gastroenterology

Figure 5

From: Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes

Figure 5

Relationship between the components of the IBD PRTI (all patients) including patient satisfaction (a), preference (b), and willingness (c) versus the Mayo endoscopy score. IBD PRTI item scores: Patient satisfaction assessment; Extremely dissatisfied with study drug = 1, Dissatisfied with study drug = 2, Neither satisfied nor dissatisfied with study drug = 3, Satisfied with study drug = 4, Extremely satisfied with study drug = 5. Patient preference assessment; Definitely prefer study drug over prior treatment = 1, Slightly prefer study drug = 2, No preference = 3, Slightly prefer prior treatment = 4, Definitely prefer prior treatment = 5. Patient willingness assessment; Would definitely use study drug again = 1, Might use study drug again = 2, Not sure = 3, Might not use study drug again = 4, Would definitely not use study drug again = 5.

Back to article page